The Microbiome Business & Science Briefing

Reporting on The Latest Microbiome Business & Scientific Developments

TRENDING

Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

Microbiome Times January 2019 Issue

Browse below or click here to Download Reader-Friendly Version

[3d-flip-book mode=”fullscreen” urlparam=”fb3d-page” id=”2236″ title=”false”]